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Hemp seed oil is well known for its nutraceutical, cosmetic and pharmaceutical
properties due to a perfectly balanced content of omega 3 and omega 6
polyunsaturated fatty acids. Its importance for human health is reflected by the success
on the market of organic goods in recent years. However, it is of utmost importance
to consider that its healthy properties are strictly related to its chemical composition,
which varies depending not only on the manufacturing method, but also on the
hemp variety employed. In the present work, we analyzed the chemical profile of ten
commercially available organic hemp seed oils. Their cannabinoid profile was evaluated
by a liquid chromatography method coupled to high-resolution mass spectrometry.
Besides tetrahydrocannabinol and cannabidiol, other 30 cannabinoids were identified
for the first time in hemp seed oil. The results obtained were processed according to an
untargeted metabolomics approach. The multivariate statistical analysis showed highly
significant differences in the chemical composition and, in particular, in the cannabinoid
content of the hemp oils under investigation.
Keywords: hemp seed oil, hemp, high-resolution mass spectrometry, cannabinoids, cannabinoids mass spectra
INTRODUCTION
Cannabis sativa L. is one of the most widespread cultivations in the world, well known for
its characteristic to produce a class of terpenophenolic compounds named phytocannabinoids
(Elsohly and Slade, 2005). According to the most recent cannabinoid inventory, at least 120
phytocannabinoids have been identified to date (Hanuš et al., 2016). They can be divided
into 11 subclasses depending on their chemical structure: cannabigerol (CBG-type), (–)-
19-tetrahydrocannabinol (19-THC-type), cannabidiol (CBD-type), cannabichromene (CBC-
type), cannabinol (CBN-type), (–)-18-tetrahydrocannabinol (18-THC-type), cannabicyclol (CBL-
type), cannabinodiol (CBND-type), cannabielsoin (CBE-type), cannabitriol (CBT-type) and
miscellaneous type (Elsohly and Slade, 2005). For long time neutral phytocannabinoids have been
considered as the actual products of cannabis inflorescence (Hanuš et al., 2016). Actually, the fresh
plant produces the acidic form of phytocannabinoids, thus it is now accepted that the neutral
forms derive from the non-enzymatic decarboxylation of their acidic counterpart. It is necessary
to underline that many phytocannabinoids that have been isolated so far are artifacts generated by
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non-enzymatic reactions occurring either in the plant
or during the analytical processes for their identification
(Hanuš et al., 2016).
The two main phytocannabinoids produced by cannabis are
CBD and THC. Whilst the latter is an intoxicating substance,
the former is completely void of the “high” effects of its isomer
THC (Mechoulam et al., 2002). On the other hand, CBD has
proved to have several pharmacological properties, thus ranking
among the most studied phytocannabinoids for its possible
therapeutic use in a number of pathologies (Pisanti et al., 2017).
Depending on the variety of cannabis plant, it can produce
predominantly either THC or CBD. It has been suggested to
distinguish cannabis between drug-type (marijuana) and fiber-
type (hemp), the former being high in THC and the latter high
in CBD. This classification is based on the intoxicating effect of
THC (Small, 2015). However, considering the recent use of CBD
as a drug, it should be more appropriate to distinguish cannabis
between THC-type and CBD-type. Furthermore, breeders have
recently selected a number of cannabis varieties, popularly called
“industrial hemp,” that predominantly produce CBG (de Meijer
and Hammond, 2005). Therefore, a CBG-type should be added
to the list. All these phytocannabinoids are produced in the
glandular trichomes, which contains a resin oil mainly made of
phytocannabinoids and terpenes (Small, 2015). Such glandular
bodies are present essentially on the female flowering and
fruiting tops of cannabis plant and their highest concentration
is measured on the bracts, the two small leaves surrounding the
seed (Small, 2015).
Hemp seed oil is becoming popular in Italy as well as
in other countries due to the healthy properties associated
to the perfectly balanced fatty acid composition that meet
the FAO/WHO recommendations (Food and Agriculture
Organization [FAO]/World Health Organization [WHO], 2008).
While being void of cannabinoids in the inside, seeds can be
contaminated on the outer surface by the sticky resin oil secreted
by the numerous glandular trichomes present on the bracts
(Ross et al., 2000). As a result, the surface of the seed will be
“dirty” with all the cannabinoids present in the resin oil of that
specific cannabis variety. As the seeds are employed mainly
for oil production, if they are cleaned properly prior to the
extraction of hemp seed oil, the latter will contain only traces
of cannabinoids. Conversely, it has been recently suggested
that some commercial hemp seed oils can carry a total THC
concentration above 10 ppm and total CBD over 1000 ppm
(Citti et al., 2018c). Therefore, cannabis variety and the seed
cleaning procedures affect, respectively the qualitative and
quantitative profile of all cannabinoids eventually present in the
hemp seed oil. In this view, it is reasonable to hypothesize that
other cannabinoids might be present in the hemp seed oil. Since
each cannabinoid is responsible for a specific pharmacological
activity (Izzo et al., 2009), it is of utmost importance to define
the cannabinoid profile of any commercially available hemp
seed oil. For instance, if the oil were produced from CBG-type
cannabis, we would expect to find a predominant concentration
of CBG, thus the oil should have specific nutraceutical properties
exerted by this cannabinoid. Finola and Futura, CBD-rich
hemp varieties, are listed in the European cannabis varieties for
industrial purposes and are indicated as the varieties of choice
for hemp oil production due to the discrete amount of seeds
produced (Galasso et al., 2016).
A number of works in the literature report the determination
of THC and CBD concentration in hemp seed oil (Bosy and Cole,
2000; Leizer et al., 2000; Lachenmeier et al., 2004), but, to the best
of our knowledge, there is no study regarding the evaluation of
the comprehensive cannabinoid profile in this cannabis product.
Our research group, and more recently other groups
(Berman et al., 2018; Calvi et al., 2018), has developed liquid
chromatography methods coupled to high-resolution mass
spectrometry detection (HPLC-HRMS) for the identification
of the different cannabinoids in cannabis medicinal extracts
based on both exact mass and match of the fragmentation
pattern (MS2) of pure analytical standards of the known
cannabinoids. Exploiting HRMS technique, it is possible to define
the comprehensive cannabinoid profile in commercial hemp seed
oils in order to address their different nutraceutical properties to
a specific cannabinoid. The present work is indeed focused on
the identification and semi-quantification of the main and best-
known cannabinoids in commercially available hemp seed oils,
CBD and THC, along with other “minor” cannabinoids, which
contribute to the final beneficial effects. A multivariate statistical
analysis (MSA) was also carried out to highlight the significant
differences among the commercial hemp seed oils.
MATERIALS AND METHODS
Chemicals and Reagents
All solvents (acetonitrile, water, 2-propanol, formic acid) were
LC-MS grade and purchased from Carlo Erba (Milan, Italy).
Certified analytical standards of CBGA, THCA, CBDA, CBDV,
19-THC, 18-THC, CBD, 19-THC-d3, CBD-d3, CBG, CBC and
CBN were purchased from Cerilliant (Sigma-Aldrich, Round
Rock, Texas). Organic hemp seed oils were bought from the
Italian market and numbered from Oil_1 to Oil_10.
Preparation of Standard Solutions and
Hemp Seed Oil Samples
Stock solutions of CBDV, CBDA, CBGA, CBG, CBD, CBN, 19-
THC,18-THC, CBC and THCA (1000 µg/mL) in methanol were
diluted in blank matrix to the final concentration of 10 µg/mL.
An aliquot of 100 µL of each sample was diluted with 890 µL
of blank matrix and 10 µL of IS (19-THC-d3 and CBD-d3,
200 µg/mL) to the final concentration of 1 µg/mL for CBDV,
CBDA, CBGA, CBG, CBD, CBN, 19-THC, 18-THC, CBC and
THCA and 2 µg/mL for IS.
For the semi-quantification of the identified cannabinoids, the
stock solution of the analytical standards mixture was diluted
with blank matrix to the final concentrations of 0.01, 0.05, 0.10,
0.25, 0.50, 0.75, and 1.00 µg/mL.
Blank matrix was obtained as described in our previous work
(Citti et al., 2018c). Briefly, 22 g of hemp seeds (cleared of
bracts) were washed with ethyl alcohol 96% (3 × 100 mL) in
order to remove cannabinoids. Subsequently, the seeds were
cold squeezed to obtain 4 mL of hemp seed oil where the level
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of cannabinoids was below the limit of detection. The final
blank matrix (20 mL) was obtained by diluting the oil with
16 mL of 2-propanol.
Authentic samples were obtained by diluting 100 µL of
hemp seed oil with 395 µL of 2-propanol and 5 µL of IS
working solution.
Quality control samples (QCs) were prepared to assess the
reliability of the statistical model by mixing a 10 µL aliquot from
each oil sample. QCs were analyzed in triplicate at the beginning
of the batch and every 10 runs.
UHPLC-HRMS/MS Analyses
LC analyses were performed on an Ultimate 3000 UHPLC
ultrahigh performance liquid chromatograph (Thermo Fisher
Scientific, San Jose, CA, United States), consisting of a vacuum
degasser, a quaternary pump, a thermostated autosampler and
a thermostated column compartment. The sampler temperature
was set at 15◦C and the column compartment temperature at
25◦C. A Poroshell 120 EC-C18 column (3.0 × 100 mm, 2.7 µm,
Agilent, Milan, Italy) was used to separate the compounds of
interest with a mobile phase composed of 0.1% formic acid
in both (A) water and (B) acetonitrile. The gradient elution
was set as follows: 0.0–45.0 min linear gradient from 5 to 95%
B; 45.1–55.0 min 95% B; 55.1–60.0 min back to 5% B and
equilibration of the column for 5 min. The total run time was
65 min. The flow rate was set at 0.3 mL/min. The sample injection
volume was 5 µL.
The UHPLC system is interfaced to a Q-Exactive Plus
mass spectrometer (Thermo Fisher Scientific, San Jose, CA,
United States) equipped with a heated electrospray ionization
(HESI) source. The optimized parameters were as follows:
capillary temperature, 320◦C; vaporizer temperature, 280◦C;
electrospray voltage, 4.2 kV (positive mode) and 3.8 kV (negative
mode); sheath gas, 55 arbitrary units; auxiliary gas, 30 arbitrary
units; S lens RF level, 45. Analyses were carried out using
Xcalibur 3.0 software (Thermo Fisher Scientific, San Jose, CA,
United States). The exact masses of the compounds were
calculated using Qual Browser in Xcalibur 3.0 software. All
FIGURE 1 | Extracted Ion Chromatograms (EICs) in positive (A) and negative (B) ionization mode of a mix solution of cannabinoid standards (1 µg/mL). From the
top: CBD, 19-THC and 18-THC ([M+H]+ 315.2319, [M–H]− 313.2173), CBG ([M+H]+ 317.2475, [M–H]− 315.2330), CBDA and THCA ([M+H]+ 359.2217, [M–H]−
357.2071), CBDV ([M+H]+ 287.2006, [M–H]− 285.1860), CBGA ([M+H]+ 361.2373, [M–H]− 359.2228), internal standards (IS) (2 µg/mL) CBD-d3 and THC-d3
([M+H]+ 318.2517, [M–H]− 313.2361), and CBN ([M+H]+ 311.2006, [M–H]− 309.1860).
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Q-Exactive parameters (RP, AGC and IT) were optimized by
direct infusion of cannabinoid analytical standards (10 µg/L)
with a flow rate of 0.1 mL/min in order to improve sensitivity
and selectivity. The analyses were acquired in FS-dd-MS2 (full
scan data-dependent acquisition) in positive and negative mode
separately at a resolving power of 70,000 FWHM at m/z 200.
The scan range was set at m/z 250–400 improving the sensitivity
of detection; the automatic gain control (AGC) was set at 3e6,
with an injection time of 100 ms. The isolation window of
the quadrupole that filters the precursor ions was set at m/z
2. Fragmentation of precursors was optimized at four values
of normalized collision energy (NCE) (20, 30, 40, and 50 eV)
by injecting working mix standard solution at a concentration
of 10 µg/L. Detection was based on calculated [M+H]+ and
[M–H]− molecular ions with an accuracy of 2 ppm, retention
time and fragments match (m/z and intensity).
Data Processing and Multivariate
Statistical Analysis
Raw LC-HRMS/MS data were processed using XCMS Online
platform (Gowda et al., 2014). In particular, the platform applies
peak detection, retention time correction, profile alignment,
and isotope annotation. The raw files were organized in
datasets and processed as a multi-group type experiment.
The parameters were set as follows: centWave for feature
detection (1m/z = 5 ppm, minimum and maximum peak
width 5 and 40 s, respectively); obiwarp settings for retention
time correction (profStep = 1); parameters for chromatogram
alignment, including mzwid = 0.025, minfrac = 0.5, and bw = 5.
The relative quantification of the identified compounds was
based on the corresponding peak areas. Metabolite identification
was based on accurate mass (within 2 ppm) and/or MS2 data
match against MS2 spectra of compounds available on mzCloud
database (HighChem LLC, Slovakia). The results output was
exported and processed with MetaboAnalyst 3.0 for MSA (Xia
and Wishart, 2016). Principal component analysis (PCA) was
obtained after data normalization by a specified feature (CBD-
d3) and autoscaling. Partial Least Square Discriminant Analysis
(PLS-DA) was performed to maximize the groups difference.
One-way ANOVA test was performed setting the adjusted p-value
cut-off at 0.01 and using the Tukey’s honest Significant Difference
post hoc test. A heatmap was built according to Euclidean
FIGURE 2 | HRMS fragmentation spectrum of cannabidiol (CBD) in positive (A) and negative (B) ionization mode.
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distance and Ward clustering algorithm on normalized and auto-
scaled data.
RESULTS
LC-HRMS Analysis and Mass
Fragmentation Characterization
The first goal of the present work was to develop a
chromatographic method able to separate the different
cannabinoids. In particular, since most of them are
isomers and show similar fragmentation spectra, their
identification is possible only according to their retention
time. A chromatographic method for the chemical profiling of
cannabis oil medicinal extracts has been previously developed
by our group (Citti et al., 2018a). This method has been adapted
to the purpose of the present work and proved to be suitable
for the separation of cannabinoids in hemp seed oil. The
separation of the compounds of interest was carried out on a
core-shell stationary phase in reverse phase mode, which showed
good performances in terms of retention of the analytes, peak
shape and resolution power (Citti et al., 2016a,b, 2018a,b,c,d).
A gradient elution was used starting from low percentages of
the organic modifier (5% acetonitrile) to 95% in 45 min. This
allowed for an optimal separation of cannabinoids from minute
18.0 of the chromatographic run. Figure 1 reports the extracted
ion chromatograms (EIC) in positive (A) and negative (B) mode
of a cannabinoid standard mixture at 1 µg/mL used to assess
the reliability of the chromatographic method. The separation
between CBDA and CBGA, CBD and CBG does not represent
an issue when working with MS detection since there is a 2.0156
amu difference between the two cannabinoids. Conversely, the
separation between 19-THC and 18-THC, which present the
same molecular ion and identical fragmentation at low NCE
(20), could be quite tricky. However, in this case, we were
able to obtain a baseline resolution using the abovementioned
chromatographic conditions.
Since very few works in the literature describe the
fragmentation mechanism of the most common cannabinoids
using an electrospray ionization source in both positive
and negative mode, the first part of the work regarded the
elucidation of the fragmentation patterns of the precursor
ions [M+H]+ and [M–H]− of the cannabinoid standards
(CBDA, CBGA, THCA, CBDV, CBD, CBG, CBN, 19-THC,
FIGURE 3 | HRMS fragmentation spectrum of 19-tetrahydrocannabinol (19-THC or THC) in positive (A) and negative (B) ionization mode.
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18-THC and CBC). In order to propose a reliable fragmentation
mechanism, we exploited the mass spectra of the cannabinoid
deuterated standards.
Cannabidiol-Type
In the LC-MS chromatogram, CBD elutes after its acidic
precursor CBDA due to its higher lipophilicity. On the other end,
shorter alkyl chain homologs, like CBDV, elute before CBDA and
CBD due to lower lipophilicity.
In positive mode, as shown in Figure 2A, CBD [M+H]+
molecular ion 315.2318 (90% relative abundance) presents a
fragment-rich spectrum, the most relevant of which are: 259.1693
(50%) deriving from the loss of four carbon units from the
terpene moiety; 235.1693 (30%) corresponding to the breakage
of the terpene with only four carbon units of this moiety left;
193.1224, which is the base peak (100%), corresponding to
olivetol with the carbon unit attached to C2 of the benzene
ring; and 181.1223 (20%) corresponding to the resorcinol moiety
(olivetol in this specific case). Furthermore, a fragment with m/z
135.1169, which is constant in most cannabinoid fragmentations
in positive mode, corresponds to the terpene moiety. It might
be easy to misinterpret the fragmentation mechanism as a
neutral loss of 56 that generates the fragment 259 can be also
obtained by breaking the side alkyl chain at the 1”–2” bond.
However, this breakage is more difficult to occur than that
on the terpene moiety. Moreover, the fragmentation spectrum
of CBD-d3 shows the presence of the three deuterium atoms
in the fragments 262.1892, 238.1890, 210.1562, 196.1420 and
184.1420. This suggests that all the fragments are originated
from the bond breakage on the terpene moiety since the
deuterium atoms are on C5′′ of the alkyl chain. The presence
of the fragment 135 in the CBD-d3 spectrum confirmed the
proposed mechanism. In negative mode (Figure 2B), CBD
molecular ion [M–H]− 313.2172 (90%) generates a limited
number of fragments, the most abundant of which are 245.1545
(100%), originated from the retro Diels-Alder and 179.1068
(40%) corresponding to the olivetol moiety. This fragmentation
mechanism was confirmed by the MS/MS spectrum of CBD-d3 in
negative mode (Supplementary Figure S1).The acidic precursor
CBDA (Supplementary Figure S2) shows a main fragment with
m/z 341.2110 (100%) in positive mode obtained from the loss
of H2O (–18). The [M+H]+ molecular ion 359.2213 is barely
visible. The other relevant fragments are 261.1485 (10%) and
219.1015 (10%), which are obtained from the breakage of the
terpene moiety at C1–C6 bond and from the terpene loss (with
only C3 left), respectively. In negative mode, CBDA molecular
ion [M–H]− 357.2072 (100%) generates two fragments with m/z
339.1965 (70%) and with m/z 313.2173 consequent to the loss
of a molecule of water and CO2, respectively, producing the
CBD molecule (30%). Besides the fragments 245.1545 (20%)
FIGURE 4 | HRMS fragmentation spectrum of cannabinol (CBN) in positive (A) and negative (B) ionization mode.
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and 179.1068 (25%), also present in the CBD spectrum, a retro
Diels-Alder reaction occurs on the molecule after the loss of
water generating the fragment 271.1341 (10%).Fragmentation
spectra of CBDV (Supplementary Figure S6) in both positive
and negative ionization mode are consistent with its pentyl
homolog CBD with a 28 amu difference (corresponding to
a (–CH2)2). Likewise, the intensity of all fragments in the
CBDV spectrum is identical to that of the fragments in the
CBD spectrum.
Tetrahydrocannabinol-Type
19- and 18-THC elute after CBD and CBN due to the
loss of a free hydroxyl group and the formation of the
dihydropyran ring, which confers higher lipophilicity. The
chromatographic conditions employed allows an optimal
separation of the two isomers, which is important when the
MS spectrum does not help with the identification. Basically,
no difference can be highlighted between 19-THC and 18-
THC in either positive or negative ionization mode at NCE
of 20 (Supplementary Figure S11). However, the literature
reports that the two molecules can be distinguished in negative
mode at NCE above 40 by the intensity of the product
ion 191.1070 with respect to the precursor ion 313.2172
(Berman et al., 2018).
19-THC spectrum in positive mode (Figure 3A) is very
similar to that of CBD. In this case, only the retention time
can be indicative of the identity of the molecule. On the other
hand, the fragmentation pattern in negative mode (Figure 3B)
shows a great difference in terms of number of fragments. THC
appears less fragmented than CBD as the fragments 245.1544
and 179.1068 show intensities below 10% and the molecular
ion [M–H]− 313.2172 is the base peak. The fragmentation
mechanism was elucidated by the analysis of19-THC-d3 spectra
(Supplementary Figure S12).
The same consideration could be made for the acidic
precursor THCA (Supplementary Figure S13), which shows a
fragmentation spectrum in positive mode similar to that of CBDA
to the point that they could be easily mistaken. Conversely, the
fragmentation of THCA in negative mode shows only a major
peak at m/z 313.2173 (45%) corresponding to the loss of CO2
to generate the “neutral” derivative THC. The loss of water leads
to a very small fragment 339.1962 (5%), which is probably more
unstable that the corresponding species obtained with CBDA.
The dihydropyran ring probably confers different chemical
FIGURE 5 | HRMS fragmentation spectrum of cannabigerol (CBG) in positive (A) and negative (B) ionization mode.
Frontiers in Plant Science | www.frontiersin.org 7 February 2019 | Volume 10 | Article 120
fpls-10-00120 February 11, 2019 Time: 15:58 # 8
Citti et al. Cannabinoid Profiling of Hemp Seed Oil
properties and reactivity to the whole molecule. Moreover, the
acidic species elutes after the neutral counterpart, opposite to the
case of CBDA/CBD.
Cannabinol-Type
CBN elutes after CBD because of the additional pyran ring, which
confers higher lipophilicity, but before THC due to the presence
of aromaticity responsible for a higher polarity compared to the
simple cyclohexane.
In positive mode (Figure 4A), CBN molecular ion [M+H]+
311.2006 (64%) shows a product ion at 293.1895 (40%) given
by the loss of water, another one at 241.1220 (30%) due to the
benzopyran ring opening, the base peak at 223.1115, which keeps
three carbon atoms of the ring, and the fragment 195.1167 (15%)
corresponding to the resorcinol moiety and one carbon atom.
In negative mode (Figure 4B), CBN fragmentation spectrum
is very simple with only very low-intensity product ions and
the molecular ion [M–H]− 309.1860, which is also the base
peak. It originates the fragment 279.1388 given by the pyran
ring opening and loss of the two methyl groups, the fragments
247.2071 and 209.1184 due to the progressive breakage of the
benzopyran ring, and the fragment 171.0806 due to the breakage
of the benzene ring of the olivetol moiety. Such fragmentation
does not occur in other cannabinoids most likely because the C–
C bond between two benzene rings is stronger and more difficult
to break than the C–C bond between a benzene ring and a
terpene moiety.
Cannabigerol-Type
CBG elutes very close to CBD, as well as CBGA elutes
immediately after CBDA. This could be explained by the slightly
higher lipophilicity of the open isoprenoid chain compared to the
closed limonene moiety.
CBG has a very simple fragmentation spectrum in both
positive and negative mode. The molecular ion [M+H]+
317.2469 is barely visible and readily breaks to give the only
product ion and base peak 193.1225, corresponding to the olivetol
moiety with the ortho-methyl group (Figure 5A). The molecular
ion [M–H]− 315.2394, which is also the base peak, is so stable that
the fragments 271.1694, 247.0978, 191.1070 and 179.1068, have
very low abundance (Figure 5B). These product ions derive from
the progressive loss of carbon units of the isoprenoid moiety.
The [M+H]+ molecular ion 361.2373 of the acidic
counterpart CBGA (Supplementary Figure S20) is not stable
and readily loses a molecule of water to give the ion 343.2279
(75%), which is then broken at C1–C2 of the isoprenoid moiety
to give the fragment 219.1023 (100%). The [M–H]− molecular
ion 359.2230 (45%) generates only two main fragments, 341.2122
(100%) and 315.2329 (35%), as a result of the loss of water and
CO2, respectively. The other fragments have very low abundance:
FIGURE 6 | HRMS fragmentation spectrum of cannabichromene (CBC) in positive (A) and negative (B) ionization mode.
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297.2223 (<5%) derives from the additional loss of water and
191.1069 (<5%) is in common with the neutral derivative CBG.
Cannabichromene-Type
CBC elutes after THC due to a ring opening and the presence
of an additional long alkyl chain on the pyran ring. Its retention
time is slightly lower than that of THCA.
CBC has a fragmentation pattern in positive mode very similar
to THC so that they are quite undistinguishable (Figure 6A). In
negative mode (Figure 6B), it is possible to discriminate CBC
from THC by the ionic abundance of the fragments. Like THC,
the molecular ion [M–H]− 313.2171 is the base peak, but unlike
THC it generates a higher product ion 245.1544 (25%) deriving
from the loss of one isoprene unit. The other two product ions,
191.1068 (55%) and 179.1068 (35%), are higher in CBG than
THC, where they are below 10%.
Identification of Cannabinoids in Hemp
Seed Oil
Hemp seed oil is an invaluable source of nutrients and other
compounds with undeniable nutraceutical properties, spanning
polyunsaturated fatty acids, polyphenols, tocopherols, proteins,
carbohydrates, lignanamides and cannabinoids, which contribute
to the overall health benefits of this functional food (Giorgi et al.,
2013; Crescente et al., 2018). While most of these classes of
compounds have been thoroughly characterized, the attention on
the cannabinoid class has been focused only on the major and
best known of them like CBD, THC and CBN. One of our recent
work extended the study to the quantification of CBG and CBDV,
with particular attention to the acidic form of CBD and THC,
CBDA and THCA, which are the predominant species found
in cold-pressed hemp seed oil (Citti et al., 2018c). However, a
comprehensive cannabinoid profile has never been defined.
FIGURE 7 | Total ion Chromatograms (TICs) of a hemp seed oil sample (oil_1) in positive (A) and negative (B) ionization mode.
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In light of the new pharmacological properties ascribed to
other cannabinoids different from the two main ones, THC and
CBD, it is crucial to evaluate their presence in the most consumed
cannabis derived food product, hemp seed oil (Hanuš et al., 2016).
To this aim, we employed the cutting-edge technology for liquid
chromatography and high-resolution mass spectrometry, which
ensures a superior level of mass accuracy and allowed for the
identification of a greater number of compounds compared to
other techniques (Citti et al., 2018b). Figure 7 shows an example
of the total ion chromatograms of a hemp seed oil sample
obtained in positive (A) and negative (B) ionization mode.
In the present work, we report the identification of 32
cannabinoids in 10 commercial hemp seed oils obtained by
organic farming. Of these, 9 cannabinoids were identified with
level 1 annotation, using the corresponding analytical standards,
and 23 were putatively identified with level 2 annotation,
according to exact mass and mass fragmentation match with
standards found in the database mzCloud and/or reported in the
literature (Salek et al., 2013). It is noteworthy that for the first time
a number of cannabinoids, which to the best of our knowledge
have never been reported, have been identified in hemp seed oil.
A list of cannabinoids was prepared according to recently
published works (Hanuš et al., 2016; Berman et al., 2018). The
LC-HRMS chromatograms were screened in order to find the
corresponding [M+H]+ and [M–H]− molecular ions. A recent
work by Berman et al. (2018) reports the mass fragmentation
spectra in negative mode of a series of cannabinoids detected
in extracts of the aerial part of cannabis plant. This helped
in the selection of 15 cannabinoids which showed a perfect
match of the fragmentation spectrum in negative ionization
mode (cannabitriolic acid (CBTA), cannabitriol (CBT),
CBGA-C4, CBDA-C1, CBDVA, CBDA-C4, cannabidiolic
acid monomethyl ether (CBDMA), cannabielsoinic acid (CBEA),
cannabinolic acid (CBNA), THCA-C1, tetrahydrocannabidivarin
(THCV), tetrahydrocannabidivarinic acid (THCVA), THCA-
C4, cannabichromevarin (CBCV), cannabichromevarinic
acid (CBCVA)). Except for CBTA, CBGA-C4 and CBEA, the
corresponding fragmentation spectrum in positive ionization
TABLE 1 | Cannabinoids identified in commercial hemp seed oil.
Class Cannabinoid RT (min) Formula [M+H]+ [M–H]−
Cannabiripsol (CBR) CBR 19.27 C21H32O4 349.2373 347.2228
Cannabitriol (CBT) CBTA 19.41 C22H28O6 391.2115 389.1970
CBT 21.91 C21H28O4 347.2217 345.2071
Cannabigerol (CBG) 6,7-Epoxy-CBGA 21.25 C22H32O5 377.2323 375.2177
6,7-Epoxy-CBG 24.41 C21H32O3 333.2424 331.2279
CBGA-C4 28.10 C21H30O4 347.2217 345.2071
CBGA 29.60 C22H32O4 361.2373 359.2228
CBG 29.77 C21H32O2 317.2475 315.2330
Cannabidiol (CBD) CBDA-C1 22.88 C18H22O4 303.1591 301.1445
CBDVA 25.44 C20H26O4 331.1904 329.1758
CBD-C1 25.75 C17H22O2 259.1693 257.1547
CBDV 26.17 C19H26O2 287.2006 285.1860
CBDA-C4 26.99 C21H28O4 345.2060 343.1915
CBD-C4 27.99 C20H28O2 301.2162 299.2017
CBDA 28.56 C22H30O4 359.2217 357.2071
CBD 29.81 C21H30O2 315.2319 313.2173
CBDMA 33.76 C23H32O4 373.2373 371.2228
Cannabielsoin (CBE) CBEA 29.27 C23H32O4 375.2166 373.2020
Cannabinol (CBN) CBN 32.65 C21H26O2 311.2006 309.1860
CBNA 33.92 C22H26O4 355.1904 353.1758
Tetrahydrocannabinol (THC) THCA-C1 28.12 C18H22O4 303.1591 301.1445
THCV 29.92 C19H26O2 287.2006 285.1860
THCVA 31.38 C20H26O4 331.1904 329.1758
THC-C4 32.05 C20H28O2 301.1803 299.2017
THCA-C4 33.46 C21H32O4 345.2060 343.1915
THC 34.09 C21H30O2 315.2319 313.2173
THCA 35.50 C22H30O4 359.2217 357.2071
Cannabichromene (CBC) CBCV 31.27 C19H26O2 287.2006 285.1860
CBCVA 32.58 C20H26O4 331.1904 329.1758
CBC 35.19 C21H30O2 315.2319 313.2173
CBCA 36.41 C22H30O4 359.2217 357.2071
Cannabicitran (CBCT) CBCT 33.15 C21H30O2 315.2319 313.2173
For each cannabinoid, the class, retention time (min), chemical formula and precursor ions ([M+H]+ and [M–H]−) are indicated.
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mode has been extracted for each cannabinoid. Moreover, four
other cannabinoids were added to the spectral mass library.
Cannabiripsol (CBR) was identified according to its similarity
with CBT as they differ only for the presence of a double bond
on the latter. 6,7-Epoxy-CBG and its acidic precursor 6,7-epoxy-
CBGA share the same fragmentation pattern as all CBG-type
cannabinoids. Cannabicitran (CBCT) was identified based on the
mass fragmentation match in mzCloud. CBD-C1, CBD-C4 THC-
C4 and CBCT were identified according to the fragmentation
spectrum obtained in positive mode as no fragmentation was
observed in negative mode. All the identified cannabinoids
with the corresponding chemical formula, retention time and
molecular ions [M+H]+ and [M–H]− are listed in Table 1.
18-THC was not detected in any of the hemp seed oil samples.
Although it derives from acid- or oxidatively promoted shift
of the endocyclic double bond of 19-THC and is presented as
more thermodynamically stable than its precursor (Hanuš et al.,
2016), the chemical environment of hemp seed oil might not be
favorable for this isomerization.
Mass fragmentation spectra in positive and negative
mode are reported in the Supplementary Material and are
available for other researchers with similar instrumental
equipment who need a possible comparison for the
identification of unknown cannabinoids. A plausible
fragmentation mechanism in both polarities is also proposed
(Supplementary Material).
Lastly, a semi-quantification was carried out in order
to provide approximate concentrations of the identified
cannabinoids, since absolute quantification is applicable only
to level 1 cannabinoids, for which authentic standards are
TABLE 2 | Semi-quantification of the identified cannabinoids.
Class Cannabinoid Oil 1 Oil 2 Oil 3 Oil 4 Oil 5 Oil 6 Oil 7 Oil 8 Oil 9 Oil 10
CBG CBGA 0.04 0.04 0.03 0.05 0.03 0.08 0.07 0.02 0.16 0.05
CBG 0.04 0.02 0.02 0.02 0.03 0.04 0.04 0.02 0.02 0.03
CBGA-C41 0.04 0.07 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00
6,7-Epoxy-CBGA1 0.00 0.11 0.06 0.00 0.00 0.00 0.00 0.02 0.00 0.02
6,7-Epoxy-CBG2 0.01 0.03 0.03 0.02 0.01 0.01 0.01 0.02 0.02 0.01
CBD CBDA 0.62 7.75 7.68 1.19 0.81 0.93 1.04 5.29 1.37 5.76
CBD 0.08 1.08 1.53 0.24 0.12 0.11 0.14 1.01 0.26 1.37
CBDA-C43 0.08 0.07 0.08 0.00 0.00 0.00 0.00 0.03 0.00 0.06
CBD-C44 0.05 0.04 0.01 0.77 0.22 0.82 0.81 0.02 0.85 0.03
CBDVA3 0.06 0.16 0.13 0.13 0.00 0.11 0.11 0.08 0.25 0.09
CBDV 0.25 0.25 0.29 0.50 0.08 0.27 0.26 0.19 0.71 0.27
CBDA-C13 0.00 0.19 0.23 0.00 0.00 0.00 0.00 0.07 0.00 0.09
CBD-C14 0.02 0.02 0.01 0.04 0.01 0.02 0.03 0.01 0.07 0.01
CBDMA3 0.07 0.00 0.00 0.21 0.07 0.19 0.22 0.00 0.31 0.00
THC THCA 0.64 0.30 0.43 2.84 0.69 1.41 1.00 0.50 0.36 0.49
THC 0.11 0.02 0.04 0.16 0.07 0.11 0.12 0.02 0.27 0.03
THCA-C45 0.00 0.00 0.00 0.02 0.00 0.00 0.03 0.00 0.23 0.00
THC-C46 0.06 0.00 0.00 0.04 0.00 0.00 0.14 0.19 0.37 0.01
THCVA5 0.62 0.00 0.00 0.89 0.67 1.16 1.12 0.1 1.85 0.06
THCV6 0.38 0.01 0.00 0.58 0.25 0.49 0.51 0.00 0.98 0.02
THCA-C15 0.05 0.00 0.00 0.12 0.09 0.18 0.18 0.00 0.41 0.00
CBC CBCA7 0.02 0.07 0.04 0.03 0.01 0.01 0.03 0.04 0.07 0.05
CBC 0.60 1.18 1.60 1.03 0.29 0.47 0.53 0.96 1.68 1.41
CBCVA7 0.00 0.00 0.00 0.12 0.02 0.10 0.01 0.00 0.12 0.00
CBCV8 0.01 0.00 0.00 0.14 0.00 0.05 0.05 0.00 0.21 0.05
CBN CBNA7 0.07 0.01 0.00 0.12 0.03 0.09 0.10 0.02 0.26 0.03
CBN 0.17 0.05 0.54 0.26 0.07 0.10 0.11 0.05 0.61 0.08
CBE CBEA7 0.02 0.02 0.10 0.08 0.03 0.04 0.07 0.03 0.00 0.06
CBT CBTA7 0.00 0.00 0.00 0.18 0.10 0.14 0.05 0.00 0.06 0.00
CBT9 0.00 0.00 0.04 0.16 0.03 0.13 0.02 0.02 0.01 0.04
CBR CBR9 0.01 0.18 0.00 0.01 0.06 0.07 0.14 0.05 0.00 0.00
CBCT CBCT9 0.00 0.12 0.13 0.00 0.00 0.00 0.00 0.09 0.01 0.10
Values are expressed in microgram per milliliter as mean of three analyses. 1For the semi-quantification of these cannabinoids, the calibration curve of CBGA was
employed. 2The calibration curve employed is that of CBG. 3The calibration curve employed is that of CBDA. 4The calibration curve employed is that of CBD. 5The
calibration curve employed is that of THCA. 6The calibration curve employed is that of THC. 7The calibration curve employed is obtained by the average ion response
for the same concentration for all standard acid cannabinoids available (CBGA, CBDA, THCA). 8The calibration curve employed is that of CBC. 9The calibration curve
employed is obtained by the average ion response for the same concentration for all standard neutral pentyl cannabinoids available (CBD, 19-THC, CBC, CBG).
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available. Absolute quantification of cannabinoids from level 2
to 41 is not viable without appropriate analytical ploys. Hence,
1As indicated by Salek et al. (2013), compounds identified with level 1 of
confidence are those whose identity is confirmed by comparing at least two
chemical properties of authentic standards with the experimental data; compounds
reported with level 2 of confidence are those putatively annotated; level 3 of
confidence refers to putatively characterized classes of compounds; level 4 of
confidence includes all unknown compounds.
the concentrations of level 1 cannabinoids (CBDA, THCA,
CBGA, CBD, 19-THC, CBC, CBDV, CBN and CBG) were
calculated by external calibration of authentic standards analyzed
in the same LC-MS conditions. The linear equations for these
cannabinoids are reported in the Supplementary Material. For
level 2 cannabinoids, for which analytical standards were not
available, we employed the calibration curve of the cannabinoid
standard with the closest structural similarity. For those acid
FIGURE 8 | Principal Component Analysis (PCA) in positive (A) and negative (B) ionization mode of LC-HRMS data of hemp seed oils. Samples are named as
“oil_number” (e.g., oil_1); the colored ellipsoids represent the 95% confidence region. Partial Least Squares Discriminant Analysis (PLS-DA) in positive (C) and
negative (D) ionization mode of the LC-HRMS data of hemp seed oils. PLS-DA is performed by rotating the PCA components in order to obtain the maximum
separation among the groups. Validation parameters: R2 = 0.915; Q2 = 0.755.
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cannabinoids with no structural similarity, the calibration curve
was set as the average ion response obtained for the same
concentration for all the available acid cannabinoid standards.
The same was applied to level 2 neutral cannabinoids, though
leaving CBDV and CBN out as they displayed completely
different ion responses most likely due to shorter alkyl chain
and additional aromatization, respectively. The results of the
semi-quantification are reported in Table 2.
Untargeted Metabolomics for
Cannabinoid Profile in Hemp Seed Oil
The ten hemp seed oil samples analyzed by LC-HRMS in FS-dd-
MS2 were processed by XCMS Online platform according to an
untargeted metabolomics approach. Untargeted metabolomics
was performed in order to highlight possible differences in the
chemical profile among the ten samples. The results output
was then processed with MetaboAnalyst 3.0, which provided
the MSA. In particular, the PCA in both positive and negative
mode (Figures 8A,B, respectively) showed a defined cluster
organization of the different groups, which results sharpened
in the Partial Least Square Discriminant Analysis (PLS-DA)
(Figures 8C,D). Such separation suggests that the chemical
composition of the different hemp seed oils is different. In
order to address the differences, we used the PCA loadings
list provided by MetaboAnalyst that indicates which variables
have the largest effect on each component. Loadings close to –
1 and 1 (anyway far from 0), were chosen as those that strongly
influenced the clusters separation. By analyzing the spectral data,
it was possible to identify several compounds, such as glucosides
(sucrose, isohamnentin, p-coumaric acid hexoside), flavonoids
(N-caffeoyltyramine, N-coumaroyltyramine, N-feruloyltyramine
isomer 1 and 2, kampferol, cannflavin B), acids (linolenic acid,
oleic acid, α-linolenic acid) and cannabinoids. Figure 9 shows all
the significant features (in red) responsible for PCA clustering.
We focused the attention on the cannabinoid group
selecting those previously identified by HRMS. With one-way
FIGURE 9 | One-way ANOVA test of the ten hemp seed oil samples. Red
points indicate statistically significant features, green points indicate features
that do not contribute to the statistical difference (adjusted p-value cut-off:
0.01, post hoc test: Tukey’s Honest Significant Difference test).
FIGURE 10 | One-way ANOVA test of the ten hemp seed oil samples limited
to the selected cannabinoids. Red points indicate statistically significant
features, green points indicate features that do not contribute to the statistical
difference (adjusted p-value cut-off: 0.01, post hoc test: Tukey’s Honest
Significant Difference test).
ANOVA test we were able to select only the statistically
significant features among all the identified cannabinoids that
contribute to determine the group distribution. Figure 10
displays in red the significant features and in green those that
determine no difference among the ten groups. Specifically,
22 cannabinoids out of 32, CBD, CBDA, CBGA-C4, CBEA,
CBCT, CBDVA, THC, THCA, CBDV, CBN, CBMA, CBCA,
CBDA-C4, CBTA, CBNA, CBT, 6,7-epoxy-CBG, CBG, THCA-
C1, CBD-C4, CBCV and THCV, ranked as statistically significant,
thus contributing to the clustering of the oils along with other
abovementioned important compounds. A direct picture of the
distribution of significant cannabinoids over the ten samples
is given in Figure 11, which represents a heatmap of the
selected data.
DISCUSSION
Hemp seed oil has been an inestimable source of nutrients
for thousands of years (Callaway, 2004). Nowadays, despite
the scientific evidence that claims beneficial biological
properties for this cannabis derived food product, people
are still skeptical about its nutritional and therapeutic value,
generally due to the potential risk ascribed to intoxicating
cannabinoids (Crescente et al., 2018). However, taking into
account that there are strict laws on THC levels in cannabis
derived products, it is of great importance to shed lights
on the beneficial effects deriving from the contribution
of other cannabinoids. Indeed, it is now a common belief
that either THC or CBD alone are less effective than
a combination of cannabinoids or of cannabinoids and
other compounds in producing the final biological activity
of hemp seed oil and other cannabis derived products
(Crescente et al., 2018).
For the first time several cannabinoids have been detected in
hemp seed oil, most of which resulted relevant in determining
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FIGURE 11 | Heatmap built with the identified cannabinoids. Color-coding consists of shades of red and blue, where higher intensity of red stands for very high
concentration and higher intensity of blue stands for very low concentration. The samples are shown in colors at the top of the heatmap, while cannabinoids are
reported on each row.
a statistical difference in the chemical composition. Although
CBDA and CBD rank first in determining the largest effect on
the chemical differences among the ten oils due to their higher
abundance, 20 other “minor” cannabinoids are also responsible
for the chemical differentiation.
This adds a new question mark on the extreme variability
in the chemical composition of hemp seed oil mostly deriving
from the hemp variety, which is unavoidably translated to
the pharmacological versatility of this product. In this context,
it is important to underline that very little is known about
the pharmacological activities of many cannabinoids, including
cannabielsoin (CBE), CBD, THC and CBG derivatives, or CBD,
THC and CBG homologs with different length of the side
alkyl chain.
In fact, whilst many works report the anti-inflammatory, anti-
oxidant, anti-epileptic properties of CBD (Costa et al., 2007;
Pisanti et al., 2017), the anticonvulsant properties of CBN (Karler
et al., 1973), the anti-inflammatory and anticancer activity of
CBG (Deiana, 2017), the antibacterial properties of CBC (Turner
and Elsohly, 1981), very little is known about the acidic species
of cannabinoids except for CBDA, which has proved to have
anticancer (Takeda et al., 2012, 2017) and antiemetic properties
(Bolognini et al., 2013).
In this view, it is extremely important to bear in mind the big
difference between the acidic and neutral form of a cannabinoid.
For example, while THC is known for its psychotropic activity,
the very few studies available in the literature suggest that THCA
is void of such effects given its presumed inability to pass the
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blood-brain barrier (Jung et al., 2009; Guillermo, 2016), but it has
shown some anti-proliferative/pro-apoptotic activity (Ligresti
et al., 2006). Several studies have explored the conversion kinetics
of THCA into THC, indicating that heat is required for this
reaction to occur and that uncomplete conversion is unavoidably
obtained at temperatures below 160◦C (Perrotin-Brunel et al.,
2011; Wang et al., 2016). Therefore, if hemp seed oil is consumed
without heating, the levels of THC will remain low and its acidic
form will be taken.
Although cannabinoids represent a small percentage among
all hemp seed oil components (proteins, carbohydrates, fatty
acids, etc.), the results obtained by MSA suggest they actively
contribute to the chemical variability of the final product.
Taking into account that each cannabinoid is responsible for a
specific biological activity, it is reasonable to hypothesize that
they participate to the overall effect generated by hemp seed
oil consumption.
Although a semi-quantification should be regarded with
different levels of confidence given the lack of analytical standards
for most of the known cannabinoids, it still represents a
useful tool for determining which cannabinoid is more likely
to produce a biological effect. Nonetheless, the results of the
semi-quantification indicated that all cannabinoids levels were
below 5 ppm, considered the THC limit recommended by the
German legislation, which is the most restrictive. Such low
concentrations could have relevant nutraceutical effects, but it is
difficult to determine the actual pharmacological evidence given
the limited scientific studies regarding the minimum effective
dose of cannabinoids. Apart from THC, there are no guidelines
concerning the maximum daily dose of the known cannabinoids
that can be consumed by a single person.
Moreover, previous works have reported that even consuming
low-THC hemp seed oil, bioaccumulation and subsequent
metabolite excretion may result in positive cannabinoid test in
urines (Callaway et al., 1997; Lehmann et al., 1997; Struempler
et al., 1997; Bosy and Cole, 2000). This consideration is applicable
to all “classical” and “minor,” intoxicating and non-intoxicating
cannabinoids, including those with unknown biological activity.
This scenario is further complicated since all cannabinoids
generally interact with each other and/or with other non-
cannabinoid compounds determining an unpredictable final
effect (Morales et al., 2017; Turner et al., 2017). Hence, the relative
proportions between cannabinoids are also important for the
final resulting effect. At this regard, our results clearly indicate
extreme variability in the cannabinoid composition between all
samples. It is then expected that this variability is translated into
a completely variable nutraceutical profile.
For this reason, even though it is not possible to explain the
extreme pharmacological versatility arisen from the combination
of all cannabinoids, the analysis and identification of as many
of them as possible in each hemp seed oil sample is crucial for
exploiting the full potential for human life and well-being of this
unique food product.
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